Column Group Iii, Lp bought $25.0M of Tenaya Therapeutics (TNYA)

Executed Mar 5 2025, disclosed Mar 7 2025, 2 days later.

Value, as filed

$25.0M

35,714,284 sh × $0.70

Executed

Mar 5 2025

the trade date, as filed

Disclosed

Mar 7 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+5.9%

+9.7% from execution

Over the 21 trading sessions from the disclosed entry session (Mar 7 2025), the stock returned +5.9% (delay-adjusted); from the execution session (Mar 5 2025), +9.7%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

CL Column Group Iii, Lp 10% owner profile →

Column Group Iii, Lp (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in TNYA. Across 1 priced purchase filing, the average 21-session return was +9.7% from execution and +5.9% from disclosure (delay-adjusted; derived). The largest single filing was $25.0M of TNYA (35,714,284 sh × $0.70, as filed), executed Mar 5 2025.

The name

TNYA TNYA TNYA · 5 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→